Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-01

Clinical Trial Update: The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of fish oil plus fenofibrate on triglyceride levels in people on HAART.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)
  • Fish oil

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Hypertriglyceridemia | Phase 2 | Status: COMPLETED